Lijuan Chen, Linyu Yang, Jie Wang, Rui Liang, He Li, Ke Tan, Li Wang, Ting Niu, Weili Zhao. "High HDAC I/IIb selective inhibitor purinostat mesylate in relapsed and refractory diffuse large B-cell lymphoma: A single agent phase IIb study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7047